In view of the role of autologous SCT in patients with multiple myeloma [12], we investigated CD38 expression on mobilized CD34+ cells from myeloma patients and the binding and effect of daratumumab on mobilized CD34+ cells in vitro. Here, CD34 is linked to AL amyloidosis.